Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 9/2022

Open Access 01-06-2022 | Hydrocephalus | Review Article

Parkinsonism in idiopathic normal pressure hydrocephalus: is it time for defining a clinical tetrad?

Authors: Giovanni Mostile, Alfonso Fasano, Mario Zappia

Published in: Neurological Sciences | Issue 9/2022

Login to get access

Abstract

Background

Association between parkinsonism and idiopathic normal pressure hydrocephalus (iNPH) still remains debated. There is already plenty of evidences in the literature suggesting that this clinical sign can be considered as an integral part of the clinical spectrum of iNPH patients.

Methods

We reviewed the possible pitfalls in the core clinical definition of iNPH based on available international diagnostic criteria, phenomenology of parkinsonism in iNPH, and neuroimaging supporting the presence of parkinsonism in iNPH.

Conclusions

We argue that the diagnostic definition of the iNPH “triad” should be possibly reconsidered as a “tetrad” also including parkinsonism.
Literature
1.
Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2:307–327CrossRef
2.
Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM (2005) Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57(3 Suppl):S4–S16PubMed
3.
Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, Takeuchi T, Kazui H, Koyama H (2008) Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 48(Suppl):S1–S23CrossRef
4.
Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, Nakajima M, Hashimoto M, Kuriyama N, Tokuda T, Ishii K, Kaijima M, Hirata Y, Saito M, Arai H, Japanese Society of Normal Pressure Hydrocephalus (2012) Guidelines for management of idiopathic normal pressure hydrocephalus : second edition. Neurol Med Chir (Tokyo) 52:775–809CrossRef
5.
Nakajima M, Yamada S, Miyajima M, Ishii K, Kuriyama N, Kazui H, Kanemoto H, Suehiro T, Yoshiyama K, Kameda M, Kajimoto Y, Mase M, Murai H, Kita D, Kimura T, Samejima N, Tokuda T, Kaijima M, Akiba C, Kawamura K, Atsuchi M, Hirata Y, Matsumae M, Sasaki M, Yamashita F, Aoki S, Irie R, Miyake H, Kato T, Mori E, Ishikawa M, Date I, Arai H, research committee of idiopathic normal pressure hydrocephalus, (2021) Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo) 61:63–97CrossRef
6.
Lobo Antunes J, Fahn S, Cote L (1983) Normal pressure hydrocephalus and Parkinson’s disease. J Neural Transm Suppl 19:225–231PubMed
7.
Krauss JK, Regel JP, Droste DW, Orszagh M, Borremans JJ, Vach W (1997) Movement disorders in adult hydrocephalus. Mov Disord 12:53–60CrossRef
8.
Molde K, Söderström L, Laurell K (2017) Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study. J Neurol 264:2141–2148CrossRef
9.
Nowak DA, Topka HR (2006) Broadening a classic clinical triad: The hypokinetic motor disorder of normal pressure hydrocephalus also affects the hand. Exp Neurol 198:81–87CrossRef
10.
Youn J, Todisco M, Zappia M, Pacchetti C, Fasano A (2022) Parkinsonism and cerebrospinal fluid disorders. J Neurol Sci 433:120019
11.
Morishita T, Foote KD, Okun MS (2010) INPH and Parkinson disease: differentiation by levodopa response. Nat Rev Neurol 6:52–56CrossRef
12.
Mostile G, Portaro G, Certo F, Luca A, Manna R, Terranova R, Altieri R, Nicoletti A, Barbagallo GMV, Zappia M (2021) iNPH with parkinsonism: response to lumbar CSF drainage and ventriculoperitoneal shunting. J Neurol 268:1254–1265CrossRef
13.
Kang K, Jeon JS, Kim T, Choi D, Ko PW, Hwang SK, Lee HW (2016) Asymmetric and upper body parkinsonism in patients with idiopathic normal-pressure hydrocephalus. J Clin Neurol 12:452–459CrossRef
14.
Ishii M, Kawamata T, Akiguchi I, Yagi H, Watanabe Y, Watanabe T, Mashimo H (2010) Parkinsonian symptomatology may correlate with CT findings before and after shunting in idiopathic normal pressure hydrocephalus. Parkinsons Dis 2010:201089PubMedPubMedCentral
15.
Broggi M, Redaelli V, Tringali G, Restelli F, Romito L, Schiavolin S, Tagliavini F, Broggi G (2016) Normal pressure hydrocephalus and parkinsonism: preliminary data on neurosurgical and neurological treatment. World Neurosurg 90:348–356CrossRef
16.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef
17.
Bologna M, Paparella G, Fasano A, Hallett M, Berardelli A (2020) Evolving concepts on bradykinesia. Brain 143:727–750CrossRef
18.
Iansek R, Danoudis M (2016) Freezing of gait in parkinson’s disease: its pathophysiology and pragmatic approaches to management. Mov Disord Clin Pract 4:290–297CrossRef
19.
Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A (2011) Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 10:734–744CrossRef
20.
Mostile G, Nicoletti A, Zappia M (2018) Vascular parkinsonism: still looking for a diagnosis. Front Neurol 9:411CrossRef
21.
Starr BW, Hagen MC, Espay AJ (2014) Hydrocephalic parkinsonism: lessons from normal pressure hydrocephalus mimics. J Clin Mov Disord 1:2CrossRef
22.
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864CrossRef
23.
Stolze H, Kuhtz-Buschbeck JP, Drücke H, Jöhnk K, Illert M, Deuschl G (2001) Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson’s disease. J Neurol Neurosurg Psychiatry 70:289–297CrossRef
24.
Bugalho P, Alves L, Miguel R (2013) Gait dysfunction in Parkinson’s disease and normal pressure hydrocephalus: a comparative study. J Neural Transm (Vienna) 120:1201–1207CrossRef
25.
Selge C, Schoeberl F, Zwergal A, Nuebling G, Brandt T, Dieterich M, Schniepp R, Jahn K (2018) Gait analysis in PSP and NPH: Dual-task conditions make the difference. Neurology 90:e1021–e1028CrossRef
26.
Davis A, Gulyani S, Manthripragada L, Luciano M, Moghekar A, Yasar S (2021) Evaluation of the effect comorbid Parkinson syndrome on normal pressure hydrocephalus assessment. Clin Neurol Neurosurg 207:106810CrossRef
27.
Ondo WG, Chan LL, Levy JK (2022) Vascular parkinsonism: clinical correlates predicting motor improvement after lumbar puncture. Mov Disord 17:91–97CrossRef
28.
Giliberto C, Mostile G, Lo Fermo S, Reggio E, Sciacca G, Nicoletti A, Zappia M (2017) Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis. Neurol Sci 38:2209–2212CrossRef
29.
Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU, Fasano A, Pacchetti C (2021) Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Mov Disord 36:124–132CrossRef
30.
Akiguchi I, Ishii M, Watanabe Y, Watanabe T, Kawasaki T, Yagi H, Shiino A, Shirakashi Y, Kawamoto Y (2008) Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol 255:1392–1399CrossRef
31.
Curran T, Lang AE (1994) Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord 9:508–520CrossRef
32.
Lenfeldt N, Larsson A, Nyberg L, Andersson M, Birgander R, Eklund A, Malm J (2008) Idiopathic normal pressure hydrocephalus: increased supplementary motor activity accounts for improvement after CSF drainage. Brain 131:2904–2912CrossRef
33.
Haslinger B, Erhard P, Kämpfe N, Boecker H, Rummeny E, Schwaiger M, Conrad B, Ceballos-Baumann AO (2001) Event-related functional magnetic resonance imaging in Parkinson’s disease before and after levodopa. Brain 124:558–570CrossRef
34.
Ouchi Y, Nakayama T, Kanno T, Yoshikawa E, Shinke T, Torizuka T (2007) In vivo presynaptic and postsynaptic striatal dopamine functions in idiopathic normal pressure hydrocephalus. J Cereb Blood Flow Metab 27:803–810CrossRef
35.
Nakayama T, Ouchi Y, Yoshikawa E, Sugihara G, Torizuka T, Tanaka K (2007) Striatal D2 receptor availability after shunting in idiopathic normal pressure hydrocephalus. J Nucl Med 48:1981–1986CrossRef
36.
Del Gamba C, Bruno A, Frosini D, Volterrani D, Migaleddu G, Benedetto N, Perrini P, Pacchetti C, Cosottini M, Bonuccelli U, Ceravolo R (2021) Is DAT imaging abnormality in normal pressure hydrocephalus always suggestive of degeneration? Neurol Sci 42:723–726CrossRef
37.
Sarica A, Quattrone A, Quarantelli M, Arcuri PP, Mechelli A, La Torre D, Vaccaro MG, Cascini GL, Quattrone A (2021) Reduced striatal DAT uptake normalizes after shunt in normal-pressure hydrocephalus. Mov Disord 36:261–262CrossRef
38.
Todisco M, Zangaglia R, Minafra B, Pisano P, Trifirò G, Bossert I, Pozzi NG, Brumberg J, Ceravolo R, Isaias IU, Fasano A, Pacchetti C (2021) Clinical outcome and striatal dopaminergic function after shunt surgery in patients with idiopathic normal pressure hydrocephalus. Neurology 96:e2861–e2873CrossRef
39.
Odagiri H, Baba T, Nishio Y, Iizuka O, Narita W, Matsuda M, Mori E (2015) Clinical characteristics of idiopathic normal pressure hydrocephalus with Lewy body diseases. J Neurol Sci 359:309–311CrossRef
Metadata
Title
Parkinsonism in idiopathic normal pressure hydrocephalus: is it time for defining a clinical tetrad?
Authors
Giovanni Mostile
Alfonso Fasano
Mario Zappia
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06119-3

Other articles of this Issue 9/2022

Neurological Sciences 9/2022 Go to the issue

Letter to the Editor

Relationship between neutrophil to lymphocyte ratio and intracranial hemorrhage in stroke

Brief Communication

A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1

Original Article

Cerebral blood flow alterations specific to freezing of gait in Parkinson’s disease

Original Article

The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients

Short Paper

Experimental animal models of migraine

Short Paper

Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol